A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection. [electronic resource]
Producer: 19970121Description: 30-52 p. digitalISSN:- 0114-5916
- Amoxicillin -- administration & dosage
- Anti-Bacterial Agents -- therapeutic use
- Bismuth -- therapeutic use
- Clarithromycin -- administration & dosage
- Drug Therapy, Combination
- Dyspepsia -- microbiology
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- drug effects
- Histamine H2 Antagonists -- therapeutic use
- Humans
- Nitroimidazoles -- therapeutic use
- Omeprazole -- administration & dosage
- Penicillins -- therapeutic use
- Peptic Ulcer -- microbiology
- Proton Pump Inhibitors
- Risk Assessment
- Tetracyclines -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.